The Clorox Company (CLX) P/E Ratio History
Historical price-to-earnings valuation from 1990 to 2026
Loading P/E history...
CLX Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, The Clorox Company (CLX) trades at a price-to-earnings ratio of 13.8x, with a stock price of $90.01 and trailing twelve-month earnings per share of $6.21.
The current P/E is 81% below its 5-year average of 72.4x. Over the past five years, CLX's P/E has ranged from a low of 16.5x to a high of 255.2x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Consumer Defensive sector median P/E of 19.6x, CLX trades at a 30% discount to its sector peers. The sector includes 149 companies with P/E ratios ranging from 0.0x to 193.7x.
Relative to the broader market, CLX trades at a notable discount to the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CLX DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CLX P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $22B | 31.4 | - | +27% | |
| $2B | 22.0 | 1.70 | -6% | |
| $1B | 5.7Lowest | 0.15Best | +538%Best | |
| $273M | 12.2 | - | +95% | |
| $346B | 22.7 | 4.07 | +8% | |
| $33B | 16.3 | - | -20% | |
| $1B | 42.2 | - | -73% | |
| $3B | 12.7 | 1.40 | +3% | |
| $1.0T | 47.6 | 4.33 | +13% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
CLX Historical P/E Data (1990–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q3 | $103.63 | $6.16 | 16.8x | -55% | |
| FY2026 Q2 | Wed Dec 31 2025 00:00:00 GM | $100.83 | $6.12 | 16.5x | -56% |
| FY2026 Q1 | $123.30 | $6.37 | 19.4x | -48% | |
| FY2025 Q4 | Mon Jun 30 2025 00:00:00 GM | $120.07 | $6.51 | 18.4x | -51% |
| FY2025 Q3 | Mon Mar 31 2025 00:00:00 GM | $147.25 | $5.56 | 26.5x | -29% |
| FY2025 Q2 | $162.41 | $3.65 | 44.5x | +19% | |
| FY2025 Q1 | Mon Sep 30 2024 00:00:00 GM | $162.91 | $2.86 | 57.0x | +52% |
| FY2024 Q4 | Sun Jun 30 2024 00:00:00 GM | $136.47 | $2.25 | 60.7x | +62% |
| FY2024 Q3 | Sun Mar 31 2024 00:00:00 GM | $153.11 | $1.94 | 78.9x | +111% |
| FY2024 Q2 | Sun Dec 31 2023 00:00:00 GM | $142.59 | $0.66 | 216.0x | +478% |
| FY2024 Q1 | Sat Sep 30 2023 00:00:00 GM | $131.06 | $0.71 | 184.6x | +394% |
| FY2023 Q4 | Fri Jun 30 2023 00:00:00 GM | $159.04 | $1.22 | 130.4x | +249% |
Average P/E for displayed period: 37.4x
Full CLX Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See CLX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CLX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CLX vs WMT
Side-by-side business, growth, and profitability comparison vs Walmart Inc..
Start ComparisonCLX — Frequently Asked Questions
Quick answers to the most common questions about buying CLX stock.
Is CLX stock overvalued or undervalued?
CLX trades at 13.8x P/E, below its 5-year average of 72.4x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does CLX's valuation compare to peers?
The Clorox Company P/E of 13.8x compares to sector median of 19.6x. The discount suggests lower growth expectations or higher risk.
What is CLX's PEG ratio?
CLX PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1990-2026.